68Ga-P16-093 and 18F-FDG PET/CT Imaging in the Same Group of Clear Cell Renal Cell Carcinoma Patients

NCT05432947 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Clear Cell Renal Cell Carcinoma

Interventions

DRUG: 68Ga-P16-093
DRUG: 18F-FDG

Sponsor

Peking Union Medical College Hospital